Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study.
Masaki YoshidaMomokazu GotohOsamu YokoyamaHidehiro KakizakiTomonori YamanishiOsamu YamaguchiPublished in: World journal of urology (2022)
ClinicalTrials.gov Identifier NCT03175029 registered 6/5/2017.